International recommendations for the secondary prevention of ischemic stroke and their realization in outpatient practice

1. <div><p>Sacco R. L., Adams R., Albers G. et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke 2006;37:577-617.</p><p>Вербицкая С.В., Парфенов В.А. Вторичная профилактика инсульта в амбулаторных условиях. Неврол журн 2011 (в печати).</p><p>Rashid P. , Leonardi-Bee J., Bath P. P. Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events. Stroke 2003;34:2741-8.</p><p>Rothwell P.M., Howard S.C., Spence J.D. for the Carotide Endarterectomy Trialist`s Collaboration. Relationship between Blood Pressure and Stroke Risk in Patients With Symptomatic Carotid Occlusive Disease. Stroke 2003;34:2583-92.</p><p>Schrader J., Luders S., Kulschewski A. et al. Mortality and morbidity after stroke, Eprosartan compared with Nitrendipine for secondary prevention. Principal results of a prospective randomised controlled study (MOSES). Stroke 2005;36:1218-26.</p><p>Haas W.K., Easton J.D., Adams H.Р. et al. A randomized trial comparing ticlopedine hydrochloride with aspirin for the prevention of stroke in high risk patients. N Engl J Med 1989;329:501-7.</p><p>Gorelick P.B., Richardson D., Kelly M. for the African American Antiplatelet Stroke Prevention Study Investigators. Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA 2003;289:2947-57.</p><p>Bhatt D., Fox K., Hacke W. et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-17.</p><p>Diener H., Bogousslavsky J., Brass L. et al. Acetylsalicylic acid on a background of clopidogrel in high-risk patients randomised after recent ischaemic stroke or transient ischaemic attack: the MATCH trial results. Lancet 2004;364:331-4.</p><p>Diener H.C., Cunha L., Forbes C. et al. European Stroke Prevention Study, 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.</p><p>Connolly S., Ezekowitz M.D., Ysuf S. et al. Dabigatran versus warfarin in patients with atrial fibrillation (ACTIVE A). N Engl J Med 2009;361:1139-51.</p><p>Amarenco P. , Bogousslavsky J., Amarenco P. et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-59.</p><p>Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991;325:445-53.</p><p>Rothwell P.M., Eliasziw M., Gutnikov S.A. et al. Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004;363:915-24.</p><p>Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomized trial: the EC/IC Bypass Study Group. N Engl J Med 1985;313:1191-200.</p></div><br />